|At amortized cost||At fair value||Derivatives with|
|in € millions||12/31/2015||12/31/2014||12/31/2015||12/31/2014||12/31/2015||12/31/2014||12/31/2015||12/31/2014|
|Securities and financial assets||4||2||1||1||–||–||5||3|
|Derivative financial instruments||–||–||65||36||22||28||87||64|
|Investments in affiliates||14||14||–||–||–||–||14||14|
|Securities and financial assets||3||3||10||7||–||–||13||10|
|Derivative financial instruments||–||–||16||6||30||26||46||32|
Other financial assets are measured at fair value in accordance with IAS 39 or they are measured at amortized cost. Investments in affiliates and other investments are measured at cost in accordance with IAS 39.46 (c) as they do not have a quoted market price in an active market and a reliable estimate of the fair value is not possible. Information on impairment is presented in note 25 “Additional Disclosures on Financial Instruments”.
As in the previous year, no financial assets have been provided as collateral for liabilities as of the end of the reporting period. Financial assets of €13 million (previous year: €9 million) were pledged with restrictions on disposal. No financial assets were provided as security for contingent liabilities to third parties for the financial years 2014 or 2015.